December 13, 2016 / 11:58 PM / a year ago

J&J ends takeover talks with Actelion

Dec 13 (Reuters) - U.S. healthcare company Johnson & Johnson said on Tuesday it has ended discussions with Actelion regarding a potential deal with Europe’s largest biotech firm.

J&J said it was not able to reach an agreement that it believed would create adequate value for its shareholders. J&J said in November that it was in preliminary talks with Actelion about a takeover of the firm, then valued at about $20 billion. (Reporting by Ismail Shakil in Bengaluru)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below